|
ZNF395 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.893400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.331800E-01 |
| Normal-vs-Stage2 |
6.931200E-01 |
| Normal-vs-Stage3 |
3.948000E-01 |
| Normal-vs-Stage4 |
6.068600E-01 |
| Stage1-vs-Stage2 |
9.113600E-01 |
| Stage1-vs-Stage3 |
5.320400E-01 |
| Stage1-vs-Stage4 |
8.370400E-01 |
| Stage2-vs-Stage3 |
7.076200E-01 |
| Stage2-vs-Stage4 |
8.932000E-01 |
| Stage3-vs-Stage4 |
8.497400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.482600E-01 |
| Normal-vs-AfricanAmerican |
2.991000E-01 |
| Normal-vs-Asian |
4.248200E-02 |
| Caucasian-vs-AfricanAmerican |
4.677600E-01 |
| Caucasian-vs-Asian |
1.143610E-01 |
| AfricanAmerican-vs-Asian |
1.439830E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.785800E-01 |
| Normal-vs-Female |
3.608800E-01 |
| Male-vs-Female |
5.666800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.057800E-01 |
| Normal-vs-Extreme_Weight |
3.292800E-01 |
| Normal-vs-Obese |
5.058100E-02 |
| Normal-vs-Extreme_Obese |
5.460800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.662800E-01 |
| Normal_Weight-vs-Obese |
2.442600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.212800E-01 |
| Extreme_Weight-vs-Obese |
1.898390E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.976800E-01 |
| Obese-vs-Extreme_Obese |
6.402500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.826600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.063900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.047200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.317200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.251000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.061200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.231400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.047800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.202400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.171800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.404200E-01 |
| Normal-VS-Type2 PRCC |
5.714000E-01 |
| Normal-VS-KIRP CIMP |
1.541440E-01 |
| Normal-VS-Unclassified PRCC |
7.568400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.143000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.463430E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.882800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.549000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.955800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.382400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.180200E-01 |
| Normal-vs-N1 |
7.207000E-01 |
| Normal-vs-N2 |
5.779800E-01 |
| N0-vs-N1 |
8.863600E-01 |
| N0-vs-N2 |
4.375200E-01 |
| N1-vs-N2 |
6.160200E-01 |
|
|
